Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Process Safety Guide Helps Scientists Reduce Runaway Reaction Risk

Published: Monday, October 08, 2012
Last Updated: Monday, October 08, 2012
Bookmark and Share
New Guide to increase process safety, limit rework, and lower related manufacturing costs.

A new, free METTLER TOLEDO Process Safety Guide entitled “Understanding the Risks: Safe Chemical Processes at Scale” helps chemists and engineers mitigate a given experiment’s runaway reaction risk to promote safer manufacturing.

Even though chemical manufacturing should be intrinsically safe, the Guide shows how appropriate process review is essential to maintaining reaction control, particularly when operating conditions deviate from expected norms.

Predominant variables discussed include reactant accumulation, high impurity sensitivity, induction issues and inaccurate kinetic assumptions.

Modeling for heat, energy accumulation, and induction is covered in depth using a semi-batch nitration reaction as an example.

Because modeling reactions in practice is typically not feasible, the Guide shows how critical process safety analysis can be reduced to a number of basic properties that accurately predict maximum temperature of the synthesis reaction (MTSR) and worst-case scenario maximum attainable temperature (MAT).

This data, in turn, can be depicted as a “Runaway Graph,” accounting for both primary and secondary reactions. This graph can then be used to effectively redesign processes to increase reaction safety, even under unexpected, adverse conditions, using techniques such as modifying concentration/feed rates and continuous vs. batch or semi-batch processing. Evaluating process criticality is also covered.

The ultimate goal of the Process Safety Guide is to achieve desired reaction outcomes-including maximum productivity-alongside optimum safety.

To learn more about effectively modeling potential runaway scenarios, and how applying these models to chemical and pharmaceutical manufacturing can help limit manufacturing hazards and reduce costs, download a copy of the Guide free at www.mt.com/AC-PSGuide.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pharma Tech Trends and Development Cost Solutions
METTLER TOLEDO’s new on-demand webinar, “Methods to Improve Chemical Process Development,” takes on the challenges of today’s pharmaceutical market.
Thursday, April 04, 2013
Scientific News
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!